Iyer et al. proposed that TCF21 played a protective role in CAD development by inhibiting SMAD3, a central transcription factor (TF) inhibiting the cellular processes that allow smooth muscle cell (SMC) to repair the vascular lesions [57]. Here, TF is linked to coronary artery disorder.